Testing modality | Indications/advantages | Resolution | Limitations |
Fluorescence in situ hybridization (FISH) | Rapid and accurate detection of aneuploidies involving chromosomes 13, 18, 21, X, and Y. Can also assess selected deletions and duplications (eg, 22q11.2 [DiGeorge] deletion syndrome). | N/A |
|
Karyotype | Used to identify aneuploidies or structural changes, such as balanced and unbalanced translocations, inversions, mosaicism, marker chromosomes, and chromosomal rings. Low level of uncertain results since variants of uncertain significance are not detected. | 5 to 10 Mb |
|
Chromosomal microarray analysis (CMA) | Used to detect smaller gains and losses of genetic material than possible with conventional karyotype. Can be performed on uncultured cells (including nonviable cells from stillborns) so rapid turnaround time. | 10 to 100 kB |
|
Targeted gene sequencing (massively parallel sequencing of specific genes or group of genes known to be associated with a genetic condition) | Used to detect a limited number of monogenic disorders. Most useful when the phenotype is clear, a specific single-gene disorder is suspected, and the gene panel includes most of the relevant genes for possible genetic disorders involving that phenotype. | Single base pair |
|
Exome sequencing (sequencing of regions of the genome known to encode proteins) | Used to detect monogenic disorders. More comprehensive than a targeted gene panel. Recommended when the fetus has a single major anomaly or multiple organ system anomalies suggestive of a possible genetic etiology, but CMA is not diagnostic or without prior CMA when the fetal phenotype strongly suggests a single-gene disorder. Also recommended in the setting of a previous fetus/child with an anomaly or anomalies suggestive of a genetic etiology but without definitive diagnosis and recurrence of similar anomalies in the current pregnancy. | Single base pair |
|
Whole genome sequencing (nonselective sequencing of coding and noncoding regions of the genome) | Used to detect monogenic disorders. Most comprehensive testing technique (can detect some variants not detectable with exome sequencing). Rapid turnaround time. | Single base pair |
|
Courtesy of Neeta Vora, MD, and Sarah Harris, MD, MS.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟